A treatment consent form sets out what you agree to before hair loss treatment begins. It tells you what is planned, what risks have been explained, what the treatment may cost, and how the clinic will handle your information.
If you do not understand or agree with a section, you can pause and ask for a clearer explanation before signing. Read the form closely, because it records the explanation you received and the conditions you accepted.
What consent means
Informed consent at a Japanese hair loss clinic requires that a doctor explain the proposed treatment, its main risks, and the alternatives. You must understand this information well enough to make a voluntary decision. Your signature records both the explanation and your choice.
Japan’s Medical Care Act requires doctors and other healthcare providers to give appropriate explanations and ensure that patients understand.
A health ministry notice on self-pay care outlines specific duties: explain fees and cancellation conditions prior to treatment, and clearly state that results may vary from person to person.
What you are agreeing to when you sign
The form should specify the treatment name, expected duration, main risks, fees, cancellation terms, and how your personal information will be managed. By signing, you agree to the outlined plan, not to a specific outcome.
Treatment plan and expected course
For hair loss treatment, the plan may include one or more of the following: oral medications, topical treatments, scalp injections, or a combination of these options. The treatment plan should specify how often each method’s used and the duration of the initial evaluation period.
For finasteride or dutasteride, the Japanese package information describes about six months as the usual period needed to judge whether the treatment is working, even though some men notice change earlier. Continuing treatment is usually necessary to keep any improvement.
Main risks and side effects
A consent form should not list every possible event, but it should name the serious or common ones that may shape your decision. For oral medicines used in male pattern hair loss, this often includes sexual side effects, liver-related changes, and mood changes.
The Japanese package insert also includes a handling warning: pregnant women, women who may be pregnant, and breastfeeding women should not touch broken or crushed tablets.
Cost, cancellation, and information handling
Hair loss treatment at a Japanese clinic is self-pay, as public health insurance does not cover it. The clinic must inform you of the total fees, the number of sessions included, and the cancellation policy before you start treatment.
Do not sign if the fee description seems incomplete. Ask for the total cost of the proposed plan and clarify what happens if you stop partway through.
Checklist for the form
| Form item | What to confirm |
|---|---|
| Treatment plan | Name of the treatment, frequency, and expected duration |
| Expected course | When effects are usually judged and that results vary |
| Main risks and side effects | Known side effects and symptoms to report |
| Handling warnings | Pregnant or breastfeeding women should not touch broken or crushed tablets |
| Fees and cancellation | Total cost, what the fees cover, and cancellation terms |
| Information and contact | How records are used and how to contact the clinic |
How Japanese rules shape consent
Consent forms for hair loss treatment can differ in wording from clinic to clinic. The legal duties, however, point to the same core areas: explanation of the treatment, known risks, options, and agreement that you understood them.
Japan’s health ministry also instructs clinics not to push same-day treatment when there is no medical reason to start immediately. If someone asks you to begin before you have had time to think, that is a reason to slow the process down.
Consent is more effective when you explain it in your own words. A review of informed consent studies found that this teach-back step enhanced understanding in all three studies that assessed it.1 You can use the same method prior to signing.
Side effects to review before signing
Side effects do not occur in every man, but the form should list the known and serious ones to monitor.
In a meta-analysis of 15 placebo-controlled trials, men who took finasteride or dutasteride were approximately 1.57 times more likely to report sexual side effects compared to those taking a placebo.2
These factors can impact sexual desire, the ability to achieve erections, ejaculation, and the volume of semen.
A review from 2021 found that depression symptoms occurred in 3.33% of finasteride users and in 2.54% of comparison patients.3 The review found no direct link between the medicine and mood changes due to the observational nature of the reports.
If your mood worsens after starting the medication, inform your doctor promptly.
Some men have sexual or mood-related symptoms that continue after stopping treatment, but research has not confirmed this. A 2025 review suggests that dutasteride can lower sperm count and motility. Men planning to have children should discuss this with their doctor before starting treatment.
The package insert includes liver function details, prompting doctors to order blood tests before starting treatment and to repeat them as necessary.
Taking your time with the decision
Review the consent form carefully before you sign it. If any section is unclear, be sure to ask for clarification.
At AGA Medical Care Clinic, you can receive an examination and counseling during your first visit. Men who start that day will have their blood drawn first.
- What treatment are you recommending for my hair loss?
- Which side effects should prompt me to contact the clinic?
- What total fees and cancellation terms should I expect?
- How will you use my photos and personal information?
In an Australian review of 481 resolved claims and complaints regarding informed consent, 77 involved cosmetic procedures, and 70% of those cases included an alleged failure to explain a specific complication.4
A meta-analysis of 42 surgical studies found that structured decision support improved knowledge in 19 of 22 studies and reduced decisional conflict in 20 of 24, although many studies had some risk of bias.5
Our doctors are here to listen to your concerns and answer your questions during consultations at our clinics in Tokyo and Yokohama. You can communicate with the doctor in English. You can also reach out with any questions through our Contact Us page before your visit, so you can take your time.
Frequently asked questions
- Do I have to sign the consent form on the first visit?
-
No. You can have the examination and counseling on the first visit, take the information home, and begin treatment on a later day. At our clinic, men who choose to start that day have blood drawn before treatment.
- Can the clinic give me the consent form in English?
-
Yes. Our clinic can provide the consent form in English, and you can speak with the doctor in English. Counselors use English materials and a translation app while explaining the plan.
- What should I do if I disagree with one part of the form?
-
Do not sign yet. Mark the section you disagree with and discuss it with the doctor or counselor before deciding whether to proceed. You can also send your question through Contact Us before your visit.
- Does signing guarantee a particular hair result?
-
No. Signing confirms that we explained the treatment, risks, fees, and cancellation terms, and that you chose to proceed. For finasteride or dutasteride, about six months of treatment is usually needed before you can judge the effect, and results vary.
References
1. Glaser, J., Nouri, S., Fernandez, A., Sudore, R. L., Schillinger, D., Klein-Fedyshin, M., & Schenker, Y. (2020). Interventions to Improve Patient Comprehension in Informed Consent for Medical and Surgical Procedures: An Updated Systematic Review. Medical Decision Making, 40(2), 119-143. https://doi.org/10.1177/0272989X19896348
2. Lee, S., Lee, Y. B., Choe, S. J., & Lee, W. S. (2019). Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis. Acta Dermato-venereologica, 99(1), 12-17. https://doi.org/10.2340/00015555-3035
3. Pompili, M., Magistri, C., Maddalena, S., Mellini, C., Persechino, S., & Baldessarini, R. J. (2021). Risk of Depression Associated With Finasteride Treatment. Journal of Clinical Psychopharmacology, 41(3), 304-309. https://doi.org/10.1097/JCP.0000000000001379
4. Bismark, M. M., Gogos, A. J., McCombe, D., Clark, R. B., Gruen, R. L., & Studdert, D. M. (2012). Legal disputes over informed consent for cosmetic procedures: a descriptive study of negligence claims and complaints in Australia. Journal of Plastic, Reconstructive & Aesthetic Surgery, 65(11), 1506-12. https://doi.org/10.1016/j.bjps.2012.05.004
5. Niburski, K., Guadagno, E., Abbasgholizadeh-Rahimi, S., & Poenaru, D. (2020). Shared Decision Making in Surgery: A Meta-Analysis of Existing Literature. The Patient, 13(6), 667-681. https://doi.org/10.1007/s40271-020-00443-6
Manabe, M., Tsuboi, R., Itami, S., Osada, S. I., Amoh, Y., Ito, T., Inui, S., Ueki, R., Ohyama, M., Kurata, S., Kono, T., Saito, N., Sato, A., Shimomura, Y., Nakamura, M., Narusawa, H., Yamazaki, M., & Drafting Committee for the Guidelines for the Diagnosis and Treatment of Male- and Female-Pattern Hair Loss (2018). Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. The Journal of Dermatology, 45(9), 1031-1043. https://doi.org/10.1111/1346-8138.14470
Pereira, A. F. J. R., & Coelho, T. O. A. (2020). Post-finasteride syndrome. Anais Brasileiros de Dermatologia, 95(3), 271-277. https://doi.org/10.1016/j.abd.2020.02.001
Gupta, A. K., & Talukder, M. (2025). Efficacy and safety of dutasteride in the treatment of alopecia: a comprehensive review. Expert Opinion on Pharmacotherapy, 26(4), 367-379. https://doi.org/10.1080/14656566.2025.2461169





